Zinc Incorporated Bovine Derived- Hydroxyappatite Xenograft in Immediately Placed Implant
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-50
SponsorSuez Canal University
About this trial
The aim of this study is to evaluate Clinical and radiographic effect of zinc incorporated bovine derived hydroxyapatite xenograft and bovine hydroxyapatite xenograft alone for immediately placed implant
Eligibility criteria
Qualifiers
Adult(male or female) patients between the ages of 21 -50 years who requiring the replacement of one or more non-restorable teeth in the mandible which will be indicated for extraction.
Adequate bone dimensions at the implant site with ridge width of at least 6 mm, the availability of at least 3mm of sound subapical bone, the presence of an intact labial bone plate, and no evidance of periapical infection on cone beam computed tomography or clinically
The peri-implant gaps larger than 1.5 mm will be included.
All patients will be physically healthy with no medical history of any systemic disease.
Disqualifiers
Smokers.
Patients with para functional habits such as bruxism and clenching
Poorly controlled systemic diseases which preclude local anesthesia or surgical procedures
Patients undergoing chemotherapy or radiotherapy and immuno-compromised patients.
Trial design
Treatments tested in this trial
- Immediate implant with bovine drived hydroxyapatite xenograft.
- immediate implant with zinc incorporated bovine drived hydroxyapatite xenograft
Treatment groups
16 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov